Cirrhosis–the common end-stage of chronic liver disease–is associated with a cascade of
events, of which intestinal bacterial overgrowth and dysbiosis are central. Bacterial toxins …

Diverse liver diseases undergo a similar pathophysiological process in which liver
regeneration follows a liver injury. Given the important role of the gut-liver axis in health and …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. Its
worldwide prevalence is rapidly increasing and is currently estimated at 24%. NAFLD is …

Human gut microbiota (GM) includes a complex and dynamic population of microorganisms
that are crucial for well‐being and survival of the organism. It has been reported as diverse …

Background and Aims Cirrhosis is associated with changes in gut microbiome composition.
Although acute-on-chronic liver failure (ACLF) is the most severe clinical stage of cirrhosis …

The human microbiome contributes metabolic functions, protects against pathogens,
educates the immune system, and through these basic functions, directly or indirectly, affects …

Objective Chronic alcohol consumption is an important cause of liver-related deaths.
Specific intestinal microbiota profiles are associated with susceptibility or resistance to …

Cirrhotic portal hypertension is characterised by development of the decompensating events
of ascites, encephalopathy, portal hypertensive bleeding and hepatorenal syndrome, which …

Portal blood flows into the liver containing the gut microbiome and its products such as
endotoxin and bacterial DNA. The cirrhotic liver acts and detoxifies as the initial site of …

Chronic liver disease encompasses diseases that have various causes, such as alcoholic
liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD). Gut microbiota …